Citius Pharmaceuticals Inc.

Citius Pharmaceuticals Inc.

World Rank (Jan-05-2024)
20,325
Market Cap (Jan-05-2024)
0.124 Billion USD
World Rank (Jul-30-2023)
18,896
Market Cap (Jul-30-2023)
0.171 Billion USD
World Rank (Jan-07-2022)
17,930
Market Cap (Jan-07-2022)
0.236 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
CTXR
Market Cap (Mar-08-2026)
0.02
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biotechnology
Company Website
CITIUS PHARMACEUTICALS, INC.
Company Profile
Citius Pharmaceuticals, Inc is a late stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products with a pipeline of anti infectives in oncology, adjunct cancer care, stem cell therapy and unique prescription. The company total assets are 43.7 million USD 2020. The headquarters is in USA.
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share